Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancer

MeSH terms

• Adenocarcinoma / complications*
• Adenocarcinoma / drug therapy
• Adult
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use
• Erlotinib Hydrochloride
• Fatal Outcome
• Hepatorenal Syndrome / chemically induced*
• Humans
• Liver Failure / chemically induced*
• Male
• Pancreatic Neoplasms / complications*
• Pancreatic Neoplasms / drug therapy
• Quinazolines / adverse effects*
• Quinazolines / therapeutic use